These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9685240)

  • 1. Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1alpha, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation.
    Posner GH; Lee JK; Wang Q; Peleg S; Burke M; Brem H; Dolan P; Kensler TW
    J Med Chem; 1998 Jul; 41(16):3008-14. PubMed ID: 9685240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
    J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
    Posner GH; Wang Q; Han G; Lee JK; Crawford K; Zand S; Brem H; Peleg S; Dolan P; Kensler TW
    J Med Chem; 1999 Sep; 42(18):3425-35. PubMed ID: 10479276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conceptually new low-calcemic oxime analogues of the hormone 1 alpha,25-dihydroxyvitamin D(3): synthesis and biological testing.
    Posner GH; Halford BA; Peleg S; Dolan P; Kensler TW
    J Med Chem; 2002 Apr; 45(8):1723-30. PubMed ID: 11931627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Petersen KS; Dolan PM; Kensler TW; Peleg S; Posner GH
    J Med Chem; 2007 Nov; 50(23):5824-32. PubMed ID: 17924616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conceptually new 20-epi-22-oxa sulfone analogues of the hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and biological evaluation.
    Posner GH; Crawford K; Siu-Caldera ML; Reddy GS; Sarabia SF; Feldman D; van Etten E; Mathieu C; Gennaro L; Vouros P; Peleg S; Dolan PM; Kensler TW
    J Med Chem; 2000 Sep; 43(19):3581-6. PubMed ID: 11000014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3).
    Kahraman M; Sinishtaj S; Dolan PM; Kensler TW; Peleg S; Saha U; Chuang SS; Bernstein G; Korczak B; Posner GH
    J Med Chem; 2004 Dec; 47(27):6854-63. PubMed ID: 15615534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin.
    Posner GH; Crawford KR; Peleg S; Welsh JE; Romu S; Gewirtz DA; Gupta MS; Dolan P; Kensler TW
    Bioorg Med Chem; 2001 Sep; 9(9):2365-71. PubMed ID: 11553477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
    Carballa DM; Seoane S; Zacconi F; Pérez X; Rumbo A; Alvarez-Díaz S; Larriba MJ; Pérez-Fernández R; Muñoz A; Maestro M; Mouriño A; Torneiro M
    J Med Chem; 2012 Oct; 55(20):8642-56. PubMed ID: 22989379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 1 alpha,25-dihydroxy vitamin D3 analogues with side chains attached to C-18: synthesis and biological activity.
    Grue-Sørensen G; Hansen CM
    Bioorg Med Chem; 1998 Nov; 6(11):2029-39. PubMed ID: 9881094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation.
    Sicinski RR; Glebocka A; Plum LA; DeLuca HF
    J Med Chem; 2007 Nov; 50(24):6154-64. PubMed ID: 17960924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-ring hydroxymethyl 19-nor analogs of the natural hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
    Hatcher MA; Peleg S; Dolan P; Kensler TW; Sarjeant A; Posner GH
    Bioorg Med Chem; 2005 Jun; 13(12):3964-76. PubMed ID: 15878279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly antiproliferative, low-calcemic, side-chain amide and hydroxamate analogs of the hormone 1alpha,25-dihydroxyvitamin D3.
    Sinishtaj S; Jeon HB; Dolan P; Kensler TW; Posner GH
    Bioorg Med Chem; 2006 Sep; 14(18):6341-8. PubMed ID: 16765598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally restricted hybrid analogues of the hormone 1 alpha,25-dihydroxyvitamin D(3): design, synthesis, and biological evaluation.
    White MC; Burke MD; Peleg S; Brem H; Posner GH
    Bioorg Med Chem; 2001 Jul; 9(7):1691-9. PubMed ID: 11425569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
    Roy S; Martel J; Tenenhouse HS
    J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
    J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
    Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1α,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo.
    Flores A; Massarelli I; Thoden JB; Plum LA; DeLuca HF
    J Med Chem; 2015 Dec; 58(24):9731-41. PubMed ID: 26630444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.